Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Apolipoprotein D Antikörper

APOD Reaktivität: Human ELISA Wirt: Maus Monoclonal D544 unconjugated
Produktnummer ABIN6963942
  • Target Alle Apolipoprotein D (APOD) Antikörper anzeigen
    Apolipoprotein D (APOD)
    Reaktivität
    • 32
    • 22
    • 20
    • 15
    Human
    Wirt
    • 41
    • 6
    • 2
    Maus
    Klonalität
    • 43
    • 6
    Monoklonal
    Konjugat
    • 23
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser Apolipoprotein D Antikörper ist unkonjugiert
    Applikation
    • 34
    • 15
    • 13
    • 13
    • 12
    • 8
    • 5
    • 3
    • 3
    • 2
    • 2
    • 2
    ELISA
    Spezifität
    Apolipoprotein D
    Aufreinigung
    Purified from in vitro cultures by protein G affinity chromatography.
    Immunogen
    Recombinant human apoD
    Klon
    D544
    Isotyp
    IgG1
    Top Product
    Discover our top product APOD Primärantikörper
  • Applikationshinweise
    For quantification of apoD in serum/ plasma samples and cell culture supernatants using ELISA. D544 is recommended as coating mAb in combination with detection mAb D263 .
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    0.5 mg/mL
    Buffer
    supplied at 0.5 mg/mL in PBS with 0.02 % sodium azide
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Store product at 4-8°C or frozen at -20°C or below. Avoid repeated freezing/ thawing.
    Haltbarkeit
    18 months
  • Kuiperij, Hondius, Kersten, Versleijen, Rozemuller, Greenberg, Schreuder, Klijn, Verbeek: "Apolipoprotein D: a potential biomarker for cerebral amyloid angiopathy." in: Neuropathology and applied neurobiology, Vol. 46, Issue 5, pp. 431-440, (2020) (PubMed).

    Herzig, Leppäluoto, Jokelainen, Meugnier, Pesenti, Selänne, Mäkelä, Ahola, Jämsä, Vidal, Keinänen-Kiukaanniemi: "Low level activity thresholds for changes in NMR biomarkers and genes in high risk subjects for Type 2 Diabetes." in: Scientific reports, Vol. 7, Issue 1, pp. 11267, (2019) (PubMed).

    Braesch-Andersen, Beckman, Paulie, Kumagai-Braesch: "ApoD mediates binding of HDL to LDL and to growing T24 carcinoma." in: PLoS ONE, Vol. 9, Issue 12, pp. e115180, (2016) (PubMed).

  • Target
    Apolipoprotein D (APOD)
    Andere Bezeichnung
    apoD (APOD Produkte)
    Synonyme
    APOD antikoerper, apod antikoerper, zgc:153593 antikoerper, AOPDGN antikoerper, Apo-D antikoerper, lipocalin antikoerper, apolipoprotein D antikoerper, apolipoprotein Da, duplicate 1 antikoerper, APOD antikoerper, CpipJ_CPIJ006492 antikoerper, CpipJ_CPIJ017615 antikoerper, CpipJ_CPIJ020105 antikoerper, apod antikoerper, apoda.1 antikoerper, Apod antikoerper
    Gen-ID
    347
    Pathways
    Platelet-derived growth Factor Receptor Signaling
Sie sind hier:
Kundenservice